Patents by Inventor Helen Lee

Helen Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240086772
    Abstract: Disclosed is a method and apparatus for learning a noise label based on test-time augmented cross entropy and noise mixing. The method includes obtaining noisy training data including clean label data and label noise data, selecting label noise for searching for mislabeled data by separating the clean label data and the label noise data from the noisy training data, and learning a classifier by mixing the noisy training data and the clean label data at a predetermined ratio.
    Type: Application
    Filed: September 13, 2023
    Publication date: March 14, 2024
    Applicants: SEOUL WOMEN'S UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Helen HONG, Hansang LEE
  • Patent number: 11762534
    Abstract: A system and a method are disclosed for simulating asset transfers (e.g., sweeps) using a user interface generated by various collections of display routines. A sweep management system may generate a graphical user interface (GUI) on a webpage to simulate sweeps. The GUI may include a list of entities rendered using a first collection of display routines and a graphical representation of some of the entities rendered using a second collection of display routines. The graphical representation may be rendered using a shared webpage object. Furthermore, callback functions are executed to perform operations based on user interactions. For example, callback functions are used to update the graphical representation after a user has dragged and dropped an entry from the list into the graphical representation.
    Type: Grant
    Filed: May 15, 2022
    Date of Patent: September 19, 2023
    Assignee: GOLDMAN SACHS & CO. LLC
    Inventors: Helen Lee Chan, Joe Peace Hopgood, Moses Song, Bruce John Horner, Lingyan Hu
  • Publication number: 20230062425
    Abstract: Combination therapy regimens including liposomal irinotecan, oxaliplatin and 5-fluorouracil are useful in the treatment of pancreatic cancer, including treatment of patients diagnosed with previously untreated metastatic adenocarcinoma of the pancreas. The combination therapy can include the administration of liposomal irinotecan, oxaliplatin, leucovorin and 5-fluorouracil once every two weeks.
    Type: Application
    Filed: April 1, 2022
    Publication date: March 2, 2023
    Applicant: Ipsen Biopharm Ltd.
    Inventors: Eliel Bayever, Sarah F. Blanchette, Jonathan Basil Fitzgerald, Daniel F. Gaddy, Bart S. Hendriks, Ashish Kalra, Helen Lee
  • Publication number: 20230011633
    Abstract: Systems and methods for scalable biometric authentication are disclosed. In one embodiment, a method for scalable biometric authentication may include: (1) receiving, by a biometric authentication computer program executed by a computer processor, a transaction request for a transaction comprising a received biometric; (2) identifying, by the biometric authentication computer program, a subset of likely customers from a set of customers for the transaction; (3) retrieving, by the biometric authentication computer program, stored biometrics for the subset of customers; (4) identifying, by the biometric authentication computer program, one of the stored biometrics for the subset of customers that matches the received biometric; and (5) retrieving, by the biometric authentication computer program, a stored payment method for the identified stored biometric.
    Type: Application
    Filed: July 7, 2022
    Publication date: January 12, 2023
    Inventors: Derek WALDRON, Akrati JOHARI, Michelle Helen LEE, Denis KOCHEDYKOV, Oleg RASSKAZOV
  • Publication number: 20230000858
    Abstract: Novel therapies for the treatment of small cell lung cancer (SCLC) include the administration of an antineoplastic therapy consisting of liposomal irinotecan administered once every two weeks, optionally including the administration of other non-antineoplastic agents to the patient such as the administration of a corticosteroid and an anti-emetic to the patient prior to the administration of the irinotecan liposome.
    Type: Application
    Filed: March 21, 2022
    Publication date: January 5, 2023
    Applicant: Ipsen Biopharm Ltd.
    Inventors: Bambang Adiwijaya, Jonathan Basil Fitzgerald, Helen Lee
  • Publication number: 20220269383
    Abstract: A system and a method are disclosed for simulating asset transfers (e.g., sweeps) using a user interface generated by various collections of display routines. A sweep management system may generate a graphical user interface (GUI) on a webpage to simulate sweeps. The GUI may include a list of entities rendered using a first collection of display routines and a graphical representation of some of the entities rendered using a second collection of display routines. The graphical representation may be rendered using a shared webpage object. Furthermore, callback functions are executed to perform operations based on user interactions. For example, callback functions are used to update the graphical representation after a user has dragged and dropped an entry from the list into the graphical representation.
    Type: Application
    Filed: May 15, 2022
    Publication date: August 25, 2022
    Inventors: Helen Lee Chan, Joe Peace Hopgood, Moses Song, Bruce John Horner, Lingyan Hu
  • Patent number: 11385771
    Abstract: A system and a method are disclosed for simulating asset transfers (e.g., sweeps) using a user interface generated by various collections of display routines. A sweep management system may generate a graphical user interface (GUI) on a webpage to simulate sweeps. The GUI may include a list of entities rendered using a first collection of display routines and a graphical representation of some of the entities rendered using a second collection of display routines. The graphical representation may be rendered using a shared webpage object. Furthermore, callback functions are executed to perform operations based on user interactions. For example, callback functions are used to update the graphical representation after a user has dragged and dropped an entry from the list into the graphical representation.
    Type: Grant
    Filed: June 16, 2021
    Date of Patent: July 12, 2022
    Assignee: Goldman Sachs & Co. LLC
    Inventors: Helen Lee Chan, Joe Peace Hopgood, Moses Song, Bruce John Horner, Lingyan Hu
  • Patent number: 11344552
    Abstract: Combination therapy regimens including liposomal irinotecan, oxaliplatin and 5-fluorouracil are useful in the treatment of pancreatic cancer, including treatment of patients diagnosed with previously untreated metastatic adenocarcinoma of the pancreas. The combination therapy can include the administration of liposomal irinotecan, oxaliplatin, leucovorin and 5-fluorouracil once every two weeks.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: May 31, 2022
    Inventors: Eliel Bayever, Sarah F. Blanchette, Jonathan Basil Fitzgerald, Daniel F. Gaddy, Bart S. Hendriks, Ashish Kalra, Helen Lee
  • Patent number: 11318131
    Abstract: Novel therapies for the treatment of small cell lung cancer (SCLC) include the administration of an antineoplastic therapy consisting of liposomal irinotecan administered once every two weeks, optionally including the administration of other non-antineoplastic agents to the patient such as the administration of a corticosteroid and an anti-emetic to the patient prior to the administration of the irinotecan liposome.
    Type: Grant
    Filed: May 17, 2017
    Date of Patent: May 3, 2022
    Inventors: Bambang Adiwijaya, Jonathan Basil Fitzgerald, Helen Lee
  • Publication number: 20210389853
    Abstract: A system and a method are disclosed for simulating asset transfers (e.g., sweeps) using a user interface generated by various collections of display routines. A sweep management system may generate a graphical user interface (GUI) on a webpage to simulate sweeps. The GUI may include a list of entities rendered using a first collection of display routines and a graphical representation of some of the entities rendered using a second collection of display routines. The graphical representation may be rendered using a shared webpage object. Furthermore, callback functions are executed to perform operations based on user interactions. For example, callback functions are used to update the graphical representation after a user has dragged and dropped an entry from the list into the graphical representation.
    Type: Application
    Filed: June 16, 2021
    Publication date: December 16, 2021
    Inventors: Helen Lee Chan, Joe Peace Hopgood, Moses Song, Bruce John Horner, Lingyan Hu
  • Publication number: 20190167661
    Abstract: Novel therapies for the treatment of small cell lung cancer (SCLC) include the administration of an antineoplastic therapy consisting of liposomal irinotecan administered once every two weeks, optionally including the administration of other non-antineoplastic agents to the patient such as the administration of a corticosteroid and an anti-emetic to the patient prior to the administration of the irinotecan liposome.
    Type: Application
    Filed: May 17, 2017
    Publication date: June 6, 2019
    Applicant: Ipsen Biopharm Ltd.
    Inventors: Bambang Adiwijaya, Jonathan Basil Fitzgerald, Helen Lee
  • Publication number: 20180355410
    Abstract: Methods are described for determining whether a subject suffering from, or suspected of suffering from, an infectious disease caused by a microbe is infected with a strain of the microbe that is susceptible to an antimicrobial agent, where there exist different strains of the microbe that are resistant to the antimicrobial agent. The methods comprise determining whether nucleic acid of the strain of the microbe infecting the subject comprises wild-type nucleotide sequence at a conserved nucleotide position at which mutation is associated with resistance to the antimicrobial agent in nucleic acid of the different resistant strains. The methods are particularly applicable for determining whether a subject suffering from, or suspected of suffering from, Gonorrhoea is infected with a strain of Neisseria gonorrhoeae that is susceptible to an antimicrobial agent. Kits for use in the methods are described, as well as methods for treatment of infectious disease.
    Type: Application
    Filed: June 17, 2016
    Publication date: December 13, 2018
    Inventors: Helen Lee, Michael Powell
  • Publication number: 20180297636
    Abstract: A three-wheeled tilting vehicle is disclosed. The vehicle can include an electronic control system that controls the tilting of the vehicle in higher speed turns for increased stability. The vehicle may also include a traction control system to provide additional stability during higher speed turns.
    Type: Application
    Filed: November 15, 2017
    Publication date: October 18, 2018
    Inventors: Helen Lee, Stephen R. Duffy, Timothy F. McLellan, Ian Armstrong Bruce
  • Patent number: 9968694
    Abstract: The present invention relates to a novel composition useful in targeted diagnostic and/or therapy of a target site, such as cancerous tissue. The composition and methods disclosed herein find particular use in diagnosing and imaging cancerous tissue. The present invention provides a new diagnostic tool for the utilization of positron emission tomography (PET) imaging technique.
    Type: Grant
    Filed: November 1, 2016
    Date of Patent: May 15, 2018
    Assignee: Merrimack Pharmaceuticals, Inc.
    Inventors: Daryl C. Drummond, Dmitri B. Kirpotin, Thomas Wickham, Bart S. Hendriks, Samuel Agresta, Helen Lee, Daniel F. Gaddy
  • Publication number: 20180078556
    Abstract: Combination therapy regimens including liposomal irinotecan, oxaliplatin and 5-fluorouracil are useful in the treatment of pancreatic cancer, including treatment of patients diagnosed with previously untreated metastatic adenocarcinoma of the pancreas. The combination therapy can include the administration of liposomal irinotecan, oxaliplatin, leucovorin and 5-fluorouracil once every two weeks.
    Type: Application
    Filed: November 10, 2017
    Publication date: March 22, 2018
    Inventors: Eliel Bayever, Sarah F. Blanchette, Jonathan Basil Fitzgerald, Daniel F. Gaddy, Bart S. Hendriks, Ashish Kalra, Helen Lee
  • Publication number: 20170217487
    Abstract: A three-wheeled tilting vehicle is disclosed. The vehicle can include an electronic control system that controls the tilting of the vehicle in higher speed turns for increased stability. The vehicle may also include a traction control system to provide additional stability during higher speed turns.
    Type: Application
    Filed: October 7, 2016
    Publication date: August 3, 2017
    Inventors: Helen Lee, Stephen R. Duffy, Timothy F. McLellan, Ian Armstrong Bruce
  • Publication number: 20170112950
    Abstract: The present invention relates to a novel composition useful in targeted diagnostic and/or therapy of a target site, such as cancerous tissue. The composition and methods disclosed herein find particular use in diagnosing and imaging cancerous tissue. The present invention provides a new diagnostic tool for the utilization of positron emission tomography (PET) imaging technique.
    Type: Application
    Filed: November 1, 2016
    Publication date: April 27, 2017
    Inventors: DARYL C. DRUMMOND, DMITRI B. KlRPOTIN, THOMAS WICKHAM, BART S. HENDRIKS, SAMUEL AGRESTA, HELEN LEE, DANIEL F. GADDY
  • Publication number: 20170049775
    Abstract: Combination therapy regimens including liposomal irinotecan, oxaliplatin and 5-fluorouracil are useful in the treatment of pancreatic cancer, including treatment of patients diagnosed with previously untreated metastatic adenocarcinoma of the pancreas. The combination therapy can include the administration of liposomal irinotecan, oxaliplatin, leucovorin and 5-fluorouracil once every two weeks.
    Type: Application
    Filed: August 19, 2016
    Publication date: February 23, 2017
    Inventors: Eliel Bayever, Sarah F. Blanchette, Jonathan Basil Fitzgerald, Daniel F. Gaddy, Bart S. Hendriks, Ashish Kalra, Helen Lee
  • Patent number: 9511155
    Abstract: The present invention relates to a novel composition useful in targeted diagnostic and/or therapy of a target site, such as cancerous tissue. The composition and methods disclosed herein find particular use in diagnosing and imaging cancerous tissue. The present invention provides a new diagnostic tool for the utilization of positron emission tomography (PET) imaging technique.
    Type: Grant
    Filed: April 17, 2013
    Date of Patent: December 6, 2016
    Assignee: MERRIMACK PHARMACEUTICALS, INC.
    Inventors: Daryl C. Drummond, Dmitri B. Kirpotin, Thomas Wickham, Bart S. Hendriks, Samuel Agresta, Helen Lee, Daniel F. Gaddy
  • Patent number: 9494584
    Abstract: Dipstick tests for detecting analyte are described. In a preferred embodiment, a multiple biotinylated antibody capable of binding analyte is bound to an anti-biotin antibody labelled with colloidal gold and wicked up the dipstick with test solution thought to contain analyte. Complex formed between analyte, biotinylated anti-analyte antibody, and colloidal gold labelled anti-biotin antibody is captured at a capture zone of the dipstick. Presence of colloidal gold label at the capture zone indicates the presence of analyte in the test solution. The sensitivity of analyte detection using such methods is an order of magnitude higher than for comparable methods in which biotinylated anti-analyte antibody bound to analyte is wicked up the dipstick in a first step, and a colloidal gold labelled anti-biotin antibody is wicked up the dipstick in a separate step. Kits for performing the tests of the invention are also described.
    Type: Grant
    Filed: June 21, 2011
    Date of Patent: November 15, 2016
    Assignee: Diagnostics for the Real World, Ltd.
    Inventors: Helen Lee, Ling Huang, Magda Anastassova Dineva, Hsiang Yun Hu